GlassScriptPhysician profile
Glenn Koteen
NPI 1366458028
$4,177.13
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,762 · 2020: $770 · 2021: $1,550 · 2022: $96.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,071.93 | 2019-2020 | |
| Janssen Biotech, INC. | $765.60 | 2019-2022 | |
| Abbvie INC. | $595.29 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $480.88 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $467.76 | 2019-2021 | |
| Pfizer INC. | $317.29 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $78.63 | 2020-2021 | |
| Braintree Laboratories, INC. | $67.42 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $64.59 | 2021 | |
| Gilead Sciences, INC. | $63.41 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $60.71 | 2019 | |
| Ucb, INC. | $49.98 | 2019 | |
| Celgene Corporation | $37.92 | 2021 | |
| Ferring Pharmaceuticals INC. | $35.99 | 2019 | |
| Merck Sharp & Dohme LLC | $11.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $7.87 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Koteen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.